tetrahydrobiopterin biosynthesis off-target sulfa drugs
introduction sulfa drugs chemotherapy bacterial infections revolutionized medicine although mechanism action understood molecular bases side effects remain obscure report sulfamethoxazole sulfa drugs interfere tetrahydrobiopterin biosynthesis inhibition sepiapterin reductase crystal structures sepiapterin reductase bound sulfa drugs reveal structurally diverse sulfa drugs achieve specific inhibition enzyme effect sulfa drugs tetrahydrobiopterin-dependent neurotransmitter biosynthesis cell-based assays provides rationale central nervous system related side effects particularly high-dose sutfamethoxazole therapy pneumorystis pneumonia findings reveal unexpected aspect pharmacology sulfa drugs might translate improved medical use
